Literature DB >> 26653213

(Mis)use of (133)Ba as a calibration surrogate for (131)I in clinical activity calibrators.

B E Zimmerman1, D E Bergeron1.   

Abstract

Using NIST-calibrated solutions of (131)Ba and (131)I in the 5mL NIST ampoule geometry, measurements were made in three NIST-maintained Capintec activity calibrators and the NIST Vinten 671 ionization chamber to evaluate the suitability of using (133)Ba as a calibration surrogate for (131)I. For the Capintec calibrators, the (133)Ba response was a factor of about 300% higher than that of the same amount of (131)I. For the Vinten 671, the Ba-133 response was about 7% higher than that of (131)I. These results demonstrate that (133)Ba is a poor surrogate for (131)I. New calibration factors for these radionuclides in the ampoule geometry for the Vinten 671 and Capintec activity calibrators were also determined. Published by Elsevier Ltd.

Entities:  

Keywords:  Activity calibrators; Barium-133; Iodine-131; Ionization chambers

Mesh:

Substances:

Year:  2015        PMID: 26653213      PMCID: PMC5054511          DOI: 10.1016/j.apradiso.2015.11.034

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  5 in total

Review 1.  Radioiodine therapy for hyperthyroidism.

Authors:  Douglas S Ross
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

Review 2.  Iodine-131-lipiodol therapy in hepatic tumours.

Authors:  Hojjat Ahmadzadehfar; Amir Sabet; Kai Wilhelm; Hans Jürgen Biersack; Jörn Risse
Journal:  Methods       Date:  2011-06-12       Impact factor: 3.608

Review 3.  Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.

Authors:  Anna M Sawka; Lehana Thabane; Luciana Parlea; Irada Ibrahim-Zada; Richard W Tsang; James D Brierley; Sharon Straus; Shereen Ezzat; David P Goldstein
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

4.  Calibration of Traceable Solid Mock (131)I Phantoms Used in an International SPECT Image Quantification Comparison.

Authors:  B E Zimmerman; L Pibida; L E King; D E Bergeron; J T Cessna; M M Mille
Journal:  J Res Natl Inst Stand Technol       Date:  2013-08-15

5.  Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma.

Authors:  Phillipe J Calais; J Harvey Turner
Journal:  World J Nucl Med       Date:  2012-09
  5 in total
  1 in total

1.  An update on 'dose calibrator' settings for nuclides used in nuclear medicine.

Authors:  Denis E Bergeron; Jeffrey T Cessna
Journal:  Nucl Med Commun       Date:  2018-06       Impact factor: 1.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.